Submit a Review & Earn an Amazon Gift Card
You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!
Submit ReviewPF 06424439 is a potent and selective DGAT2 inhibitor (IC50 = 14 nM). Exhibits no significant activity at MGAT1-3 or DGAT1. Reduces triglyderide synthesis in human hepatocytes in vitro. Reduces plasma triglyceride and cholesterol levels in a rat dyslipidemia model. Orally bioavailable.
Sold for research purposes under agreement from Pfizer Inc.
M. Wt | 536.05 |
Formula | C22H26ClN7O.CH4O3S |
Storage | Desiccate at RT |
Purity | ≥98% (HPLC) |
CAS Number | 1469284-79-4 |
PubChem ID | 89854212 |
InChI Key | ZSTFDNQQOJUJFL-XFULWGLBSA-N |
Smiles | ClC(C=N1)=CN1C2(CC2)C3=NC4=CC=C(N5C[C@H](C(N6CCCC6)=O)CCC5)N=C4N3.O=S(C)(O)=O |
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Solvent | Max Conc. mg/mL | Max Conc. mM | |
---|---|---|---|
Solubility | |||
water | 53.6 | 100 | |
DMSO | 53.6 | 100 |
The following data is based on the product molecular weight 536.05. Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.87 mL | 9.33 mL | 18.65 mL |
5 mM | 0.37 mL | 1.87 mL | 3.73 mL |
10 mM | 0.19 mL | 0.93 mL | 1.87 mL |
50 mM | 0.04 mL | 0.19 mL | 0.37 mL |
References are publications that support the biological activity of the product.
Futatsugi et al (2015) Discovery and optimization of imidazopyridine-based inhibitors of diacylglycerol acyltransferase 2 (DGAT2). J.Med.Chem. 58 7173 PMID: 26349027
If you know of a relevant reference for PF 06424439, please let us know.
Keywords: PF 06424439, PF 06424439 supplier, PF06424439, diacylglyercol, O-Acyltransferases, DGAT2, inhibitors, inhibits, potent, selective, orally, bioavailable, dyslipidemia, Diacylglycerol, O-Acyltransferase, 6348, Tocris Bioscience
Citations are publications that use Tocris products. Selected citations for PF 06424439 include:
Jian et al (2020) ABHD5 suppresses cancer cell anabolism through lipolysis-dependent activation of the AMPK/mTORC1 pathway. J Biol Chem 296 100104 PMID: 33219129
Kai et al (2021) BATF Regulates T Regulatory Cell Functional Specification and Fitness of Triglyceride Metabolism in Restraining Allergic Responses. J Immunol 206 2088-2100 PMID: 33879580
Naomi P et al (2023) An AI-guided screen identifies probucol as an enhancer of mitophagy through modulation of lipid droplets. PLoS Biol 21 e3001977 PMID: 36862640
Soeren S et al (2022) Reducing lipid bilayer stress by monounsaturated fatty acids protects renal proximal tubules in diabetes. Elife 11 PMID: 35550039
Do you know of a great paper that uses PF 06424439 from Tocris? Please let us know.
Average Rating: 5 (Based on 1 Review.)
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Filter by: